(Q46179554)
Statements
A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission (English)
Juretzka M
Hensley ML
Tew W
Konner J
Aghajanian C
Leitao M
Iasonos A
1 January 2008